Temaz and Oxervate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Temaz (temazepam) and Oxervate (cenegermin-bkbj). Common drug interactions include malaise among females and eye pain among males.

The phase IV clinical study analyzes what interactions people have when they take Temaz and Oxervate. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.

What is Oxervate?

Oxervate has active ingredients of cenegermin-bkbj. eHealthMe is studying from 7,219 Oxervate users. Check the latest studies of Oxervate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 18, 2026

33 people who take Temaz and Oxervate together, and have interactions are studied.

What are the common drug interactions of Temaz and Oxervate, by gender? *:

female:

Malaise (a feeling of general discomfort or uneasiness)
Visual impairment
Corneal thinning
Eye swelling
Bone pain
Headache (pain in head)
Influenza
Pain in extremity
Spinal fracture (fracture in one of vertebrae)
Urinary tract infection

male:

Eye pain
Hospitalisation
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Drug ineffective
Eyelid irritation
Vision blurred

What are the common drug interactions of Temaz and Oxervate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Eye pain

60+:

Eye irritation
Eye pain
Vision blurred
Pain in extremity
Drug ineffective
Erythema (redness of the skin)
Eye swelling
Headache (pain in head)
Lacrimation increased
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)

What are the existing conditions these people have? *

Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 31 people, 93.94%
Hypoaesthesia Eye (reduced sense of touch or sensation on eyes): 4 people, 12.12%

* Approximation only. Some reports may have incomplete information.

Do you take Temaz and Oxervate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously